Marlan D Walker insider trades: TherapeuticsMD (TXMD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marlan reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | TXMD | ↑ Buy | 490 | $1.00 | $489 | Direct | Apr 15, 2025 (1d) |
| Apr 10, 2025 | TXMD | ↑ Buy | 2,303 | $0.87 | $2K | Direct | Apr 10, 2025 (0d) |
| Dec 7, 2023 | TXMD | ↓ Sell | 19,050 | $2.29 | $44K | Direct | Dec 7, 2023 (0d) |
| Apr 12, 2023 | TXMD | ↓ Sell | 1,170 | $3.65 | $4K | Direct | Apr 14, 2023 (2d) |
| Dec 6, 2022 | TXMD | ↓ Sell | 1,048 | $4.95 | $5K | Direct | Dec 9, 2022 (3d) |
| May 11, 2021 | TXMD | ↓ Sell | 21,592 | $1.04 | $22K | Direct | May 12, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Marlan D Walker's insider trades
Marlan D Walker is Chief Executive Officer at TherapeuticsMD (TXMD). Since May 11, 2021, Marlan has reported 2 open-market purchases worth $2K and 4 sales worth $76K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (6 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.